Next Article in Journal
Monitoring the Response of Cyclin-Dependent Kinase 4/6 Inhibitors with Mean Corpuscular Volume
Previous Article in Journal
Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer
 
 
Review

Article Versions Notes

Curr. Oncol. 2024, 31(9), 5709-5721; https://doi.org/10.3390/curroncol31090423
Action Date Notes Link
article xml file uploaded 23 September 2024 12:15 CEST Original file -
article xml uploaded. 23 September 2024 12:15 CEST Update https://www.mdpi.com/1718-7729/31/9/423/xml
article pdf uploaded. 23 September 2024 12:15 CEST Version of Record https://www.mdpi.com/1718-7729/31/9/423/pdf
article html file updated 23 September 2024 12:18 CEST Original file https://www.mdpi.com/1718-7729/31/9/423/html
Back to TopTop